Amneal Pharmaceuticals has submitted another new drug application (NDA) for its dihydroergotamine (DHE ... administration is via nasal spray or injection. If approved, Amneal’s product would ...

The approval of exenatide 1.2 ml and 2.4 ml prefilled pen injection ... that it has resubmitted to the FDA its new drug application for dihydroergotamine prefilled syringe autoinjector for ...

Amneal Pharmaceuticals (NASDAQ:AMRX) has received FDA approval for its generic version of the ... a prefilled syringe autoinjector of the drug dihydroergotamine, or DHE, for the treatment of ...

DHE is administered as a nasal spray form (Migranal®, Valeant Pharmaceuticals, QC, Canada) or by injection ... Every 6–8 h. Dihydroergotamine mesylate – generic, DHE 45® 1 mg/ml ampules ...

Dihydroergotamine in an orally inhaled form ... synchronized mechanism and is shown to provide significantly increased drug delivery compared with conventional pressurized metered-dose inhalers.

First, the Company has resubmitted to the U.S. Food and Drug Administration (FDA) its new drug application (NDA) for dihydroergotamine ... both as ampules for injection or as a nasal spray ...